Publications by authors named "A M Carnahan"
COVID-19 vaccine effectiveness against symptomatic infection with SARS-CoV-2 BA.1/BA.2 lineages among adults and adolescents in a multicentre primary care study, Europe, December 2021 to June 2022.
Charlotte Lanièce Delaunay Iván Martínez-Baz Noémie Sève Lisa Domegan Clara Mazagatos AnnaSara Carnahan
Euro Surveill
March 2024
BackgroundScarce European data in early 2021 suggested lower vaccine effectiveness (VE) against SARS-CoV-2 Omicron lineages than previous variants.AimWe aimed to estimate primary series (PS) and first booster VE against symptomatic BA.1/BA.
View Article and Find Full Text PDFThe diets of the eight species of ursids range from carnivory (e.g., polar bears, Ursus maritimus) to insectivory (e.
View Article and Find Full Text PDFArticle Synopsis
- * The study included 38,058 patients and found that VE against A(H3N2) was 36%, while VE was higher against A(H1N1)pdm09 at 46% and even higher against influenza B at 76%, with varying effectiveness based on age group and target population.
- * Overall, results showed high vaccine effectiveness particularly among children and against influenza B, but lower effectiveness rates were reported for the A(H1N1)pdm09
Background: In 2021-2022, influenza A viruses dominated in Europe. The I-MOVE primary care network conducted a multicentre test-negative study to measure influenza vaccine effectiveness (VE).
Methods: Primary care practitioners collected information on patients presenting with acute respiratory infection.